Drug intelligence / Profile preview

5-MOMIPP

Development stage
Preclinical
Lead developer
The University of Toledo
Modality
Small Molecules
Administration
Oral
01

Overview

5-MOMIPP (3-(5-methoxy-2-methyl-1H-indol-3-yl)-1-(4-pyridinyl)-2-propene-1-one) is a synthetic indole-based chalcone belonging to the indolyl-pyridinyl-propenone class. Developed by researchers at the University of Toledo, it is a prototypical inducer of methuosis, a novel form of caspase-independent, non-apoptotic cell death. This mechanism involves the massive vacuolization of macropinosome and endosome compartments, leading to metabolic catastrophe and cell rupture. 5-MOMIPP has demonstrated cytotoxic activity in glioblastoma and other cancer cell lines. It is often used as a reference compound in structure-activity relationship studies, such as those that identified its analog 6-MOMIPP, which possesses a distinct mechanism of action involving microtubule disruption.

Other names
3-(5-methoxy-2-methyl-1H-indol-3-yl)-1-(4-pyridinyl)-2-propene-1-one
02

Targets

PIKFYVE (Phosphoinositide kinase, FYVE-type zinc finger containing enzyme)

Beyond the preview

Go deeper on 5-MOMIPP.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 5-MOMIPP.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call